Works matching IS 13520504 AND DT 2014 AND VI 21 AND IP 5

Results: 9

Effect of vitamin D supplementation on pegylated interferon/ribavirin therapy for chronic hepatitis C genotype 1b: a randomized controlled trial.
Published in:
Journal of Viral Hepatitis, 2014, v. 21, n. 5, p. 348, doi. 10.1111/jvh.12146
By:
- Yokoyama, S.;
- Takahashi, S.;
- Kawakami, Y.;
- Hayes, C. N.;
- Kohno, H.;
- Tsuji, K.;
- Aisaka, Y.;
- Kira, S.;
- Yamashina, K.;
- Nonaka, M.;
- Moriya, T.;
- Kitamoto, M.;
- Aimitsu, S.;
- Nakanishi, T.;
- Kawakami, H.;
- Chayama, K.
Publication type:
Article
Impact of age on viral kinetics of peginterferon alfa-2a/ribavirin in chronic hepatitis C: final analysis from the PROPHESYS cohort.
Published in:
Journal of Viral Hepatitis, 2014, v. 21, n. 5, p. 377, doi. 10.1111/jvh.12179
By:
- Aronsohn, A.;
- Ancuta, I.;
- Caruntu, F.;
- Coppola, C.;
- Delic, D.;
- Digiacomo, A.;
- Dusheiko, G. M.;
- Lengyel, G.;
- Marcellin, P.;
- Orlandini, A.;
- Pruthi, J.;
- Silva, G. F.;
- Tallarico, L.;
- Schmitz, M.;
- Tatsch, F.;
- Korner, E.;
- Cheinquer, H.
Publication type:
Article
Adaptive response in hepatitis B virus infection.
Published in:
Journal of Viral Hepatitis, 2014, v. 21, n. 5, p. 305, doi. 10.1111/jvh.12255
By:
- Loggi, E.;
- Gamal, N.;
- Bihl, F.;
- Bernardi, M.;
- Andreone, P.
Publication type:
Article
Efficacy and safety of telaprevir ( TVR) triple therapy in a 'real-life' cohort of 102 patients with HCV genotype 1: interim analysis after 24 weeks of treatment.
Published in:
Journal of Viral Hepatitis, 2014, v. 21, n. 5, p. 333, doi. 10.1111/jvh.12145
By:
- Werner, C. R.;
- Franz, C.;
- Egetemeyr, D. P.;
- Janke‐Maier, P.;
- Malek, N. P.;
- Lauer, U. M.;
- Berg, C. P.
Publication type:
Article
Risk factors for hepatocellular carcinoma in hepatitis C patients with normal alanine aminotransferase treated with pegylated interferon and ribavirin.
Published in:
Journal of Viral Hepatitis, 2014, v. 21, n. 5, p. 357, doi. 10.1111/jvh.12151
By:
- Harada, N.;
- Hiramatsu, N.;
- Oze, T.;
- Morishita, N.;
- Yamada, R.;
- Hikita, H.;
- Miyazaki, M.;
- Yakushijin, T.;
- Miyagi, T.;
- Yoshida, Y.;
- Tatsumi, T.;
- Kanto, T.;
- Kasahara, A.;
- Oshita, M.;
- Mita, E.;
- Hagiwara, H.;
- Inui, Y.;
- Katayama, K.;
- Tamura, S.;
- Yoshihara, H.
Publication type:
Article
Telaprevir impairs renal function and increases blood ribavirin concentration during telaprevir/pegylated interferon/ribavirin therapy for chronic hepatitis C.
Published in:
Journal of Viral Hepatitis, 2014, v. 21, n. 5, p. 341, doi. 10.1111/jvh.12162
By:
- Karino, Y.;
- Ozeki, I.;
- Hige, S.;
- Kimura, M.;
- Arakawa, T.;
- Nakajima, T.;
- Kuwata, Y.;
- Sato, T.;
- Ohmura, T.;
- Toyota, J.
Publication type:
Article
Meta-analysis of observational studies: hepatitis C and survival after renal transplant.
Published in:
Journal of Viral Hepatitis, 2014, v. 21, n. 5, p. 314, doi. 10.1111/jvh.12148
By:
- Fabrizi, F.;
- Martin, P.;
- Dixit, V.;
- Messa, P.
Publication type:
Article
Eradicating hepatitis C virus ameliorates insulin resistance without change in adipose depots.
Published in:
Journal of Viral Hepatitis, 2014, v. 21, n. 5, p. 325, doi. 10.1111/jvh.12143
By:
- Milner, K‐L.;
- Jenkins, A. B.;
- Trenell, M.;
- Tid‐Ang, J.;
- Samocha‐Bonet, D.;
- Weltman, M.;
- Xu, A.;
- George, J.;
- Chisholm, D. J.
Publication type:
Article
Attendance at specialist hepatitis clinics and initiation of antiviral treatment among persons chronically infected with hepatitis C: examining the early impact of Scotland's Hepatitis C Action Plan.
Published in:
Journal of Viral Hepatitis, 2014, v. 21, n. 5, p. 366, doi. 10.1111/jvh.12153
By:
- McDonald, S. A.;
- Hutchinson, S. J.;
- Innes, H. A.;
- Allen, S.;
- Bramley, P.;
- Bhattacharyya, D.;
- Carman, W.;
- Dillon, J. F.;
- Fox, R.;
- Fraser, A.;
- Goldberg, D. J.;
- Kennedy, N.;
- Mills, P. R.;
- Morris, J.;
- Stanley, A. J.;
- Wilks, D.;
- Hayes, P. C.
Publication type:
Article